
Alnylam: Onpattro In The ATTR Amyloidosis Cardiomyopathy Market
alexsl/E+ via Getty Images Shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) surged last month after the company reported positive topline results from the APOLLO-B trial of Onpattro in ATTR amyloidosis patients with cardiomyopathy. The trial met the […]